Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Herz ; 36(5): 410-6, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21755348

RESUMO

Revascularization of coronary artery lesions should be based on objective evidence of ischemia, as recommended by the guidelines of the European Society of Cardiology. However, even in the case of stable coronary artery disease and elective percutaneous coronary intervention (PCI), pre-procedural noninvasive stress test results are available in a minority of patients only. It is common practice for physicians to make decisions on revascularization in the catheterization laboratory after a cursory review of the angiogram, despite the well-recognized inaccuracy of such an approach. Myocardial fractional flow reserve (FFR) measured by a coronary pressure wire is a specific index of the functional significance of a coronary lesion, with superior diagnostic accuracy for the detection of ischemia than any noninvasive stress test. FFR trials on patients with single and multivessel disease, such as the DEFER and FAME studies, have demonstrated that the clinical benefit of PCI with respect to patient outcome is greatest when revascularization is limited to lesions inducing ischemia, whereas lesions not inducing ischemia should be treated medically.


Assuntos
Angioplastia Coronária com Balão/métodos , Doença da Artéria Coronariana/fisiopatologia , Doença da Artéria Coronariana/terapia , Reserva Fracionada de Fluxo Miocárdico/fisiologia , Cateterismo Cardíaco , Doença da Artéria Coronariana/diagnóstico , Humanos , Isquemia Miocárdica/diagnóstico , Isquemia Miocárdica/fisiopatologia , Isquemia Miocárdica/terapia , Valor Preditivo dos Testes , Prognóstico
4.
Eur J Med Res ; 13(8): 379-82, 2008 Aug 18.
Artigo em Inglês | MEDLINE | ID: mdl-18952520

RESUMO

Coronary angiograms performed at the time of an acute coronary syndrome typically present vessel occlusions, ruptured plaques or thrombotic lesions that require reperfusion therapy. However, occasionally, no coronary artery stenoses are detected. Myocardial ischemia frequently causes left ventricular wall motion abnormalities that can be seen easily by echocardiography. In our study we aimed to analyze echocardiographic findings in patients with acute coronary syndrome and normal angiogram. After standardized risk stratification, a total of 897 patients were classified as an acute coronary syndrome and underwent a coronary angiography immediately. In 76/897 patients angiography excluded coronary macroangiopathy. Routine echocardiographic assessment in patients with normal angiogram showed in 21.1% a reduced left ventricular systolic function and 32.9% presented with segmental wall motion abnormalities. In summary, by detection of segmental wall motion abnormalities in 1/3 of patients with suspected acute coronary syndrome and normal angiogram, obviously, an echocardiographic evaluation in this patient population is of clinical relevance. Recommendations for performing echocardiography in patients with suspected acute coronary syndromes independent of angiographic findings are strongly supported. Further analyses should implement echocardiographic techniques as contrast and tissue doppler imaging.


Assuntos
Síndrome Coronariana Aguda/diagnóstico , Síndrome Coronariana Aguda/patologia , Angiografia Coronária/métodos , Ecocardiografia/métodos , Idoso , Doença da Artéria Coronariana/diagnóstico , Doença da Artéria Coronariana/patologia , Feminino , Coração/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Biológicos , Isquemia Miocárdica/patologia , Prognóstico
5.
Versicherungsmedizin ; 60(3): 118-21, 2008 Sep 01.
Artigo em Alemão | MEDLINE | ID: mdl-18807342

RESUMO

Current recommendations of the German Cardiac Society on percutaneous coronary interventions (PCI) summarise the database available for the use of drug-eluting stents (DES) for the treatment of symptomatic coronary artery stenoses. This analysis concludes that the safety and efficacy of drug-eluting stent platforms have been shown in on- and off-label situations. However, stenting with DES should be critically examined and evaluated in each patient. The decision to use a DES depends on the analysis of the individual morbidity, history of cardio-vascular disease and the specific coronary morphology. Patients characterised by a high risk of restenosis following PCI benefit in particular from DES use. In these cases, the off-label implantation of DES is indicated and necessary.


Assuntos
Prótese Vascular/normas , Reestenose Coronária/prevenção & controle , Reestenose Coronária/cirurgia , Implantes de Medicamento/normas , Fibrinolíticos/administração & dosagem , Guias de Prática Clínica como Assunto , Stents/normas , Alemanha , Humanos
6.
J Cardiovasc Surg (Torino) ; 49(4): 539-43, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18665119

RESUMO

AIM: Aortic valve replacement is a standard procedure for the treatment of severe aortic valve stenosis. Due to lower flow velocities stentless valves are associated with a more effective regression of left ventricular hypertrophy in comparison to stented valves. However, mismatch between body surface area and valve size supports unfavourable hemodynamic results. The aim of the study was to analyze hemodynamic parameters by echocardiography after implantation of the Shelhigh SuperStentless bioprosthesis and to analyze the occurrence of patient-prosthesis mismatch and left ventricular remodelling in this specific valve type. METHODS: A total of 20 patients with severe aortic stenosis underwent implantation of a Shelhigh Super Stentless prosthesis. Clinical and echocardiographic assessment was done prior to, immediate after and six months after surgery. RESULTS: All surgical procedures were successful, no surgery-related complication was documented perioperatively. One patient died after development of multiorgan failure. Echocardiography during the first eight days after surgery showed mean gradients of 16 mmHg, mean valve orifice areas of 1.8 cm(2) and indexed effective orifice areas at 0.95 cm(2)/m(2). Six-months follow-up data were obtained in 19/20 patients. There were no relevant changes in echocardiographic hemodynamic findings at the time of follow-up measurements. Significant regression of left ventricular hypertrophy was shown (P=0.0088). A patient-prosthesis mismatch occurred in one patient (0.54 cm(2)/m(2)). No recurrent symptoms were documented. CONCLUSION: Patient-prosthesis mismatch after implantation of SuperStentless Shelhigh prosthesis is rare. A significant regression of left ventricular hypertrophy could be shown after six months. Hemodynamic valve function assessed by echocardiography may be predicted early after surgery.


Assuntos
Estenose da Valva Aórtica/cirurgia , Valva Aórtica/cirurgia , Implante de Prótese de Valva Cardíaca/instrumentação , Próteses Valvulares Cardíacas , Hipertrofia Ventricular Esquerda/cirurgia , Seleção de Pacientes , Remodelação Ventricular , Idoso , Valva Aórtica/diagnóstico por imagem , Estenose da Valva Aórtica/diagnóstico por imagem , Estenose da Valva Aórtica/fisiopatologia , Feminino , Implante de Prótese de Valva Cardíaca/efeitos adversos , Ventrículos do Coração/fisiopatologia , Hemodinâmica , Humanos , Hipertrofia Ventricular Esquerda/diagnóstico por imagem , Hipertrofia Ventricular Esquerda/etiologia , Hipertrofia Ventricular Esquerda/fisiopatologia , Masculino , Estudos Prospectivos , Desenho de Prótese , Fatores de Tempo , Resultado do Tratamento , Ultrassonografia
7.
Dtsch Med Wochenschr ; 131(39): 2134-8, 2006 Sep 29.
Artigo em Alemão | MEDLINE | ID: mdl-16991027

RESUMO

BACKGROUND AND OBJECTIVE: Left main coronary artery disease (LMCA) is still a widely accepted indication for coronary artery bypass surgery. Intermediate LMCA disease, however, often cannot be evaluated reliably on the basis of clinical and angiographic information alone. The deferral of surgical revascularization based on fractional flow reserve (FFR) measurements has been shown to be safe and feasible when taking an FFR value of (3) 0.75 as cutoff. This study was performed to compare the accuracy of visual angiographic assessment of intermediate LMCA stenoses by experienced interventional cardiologists with functional assessment by FFR in a patient population with excellent long-term outcome after deferral of surgery on the basis of FFR measurements. PATIENTS AND METHODS: 24 of 51 consecutive patients with intermediate LMCA disease were deferred from surgery based on an FFR value of > or = 0.75. Each angiogram was retrospectively reviewed independently by three experienced interventional cardiologists. Reviewers were blinded to initial FFR results, clinical data, and clinical outcome and asked to classify each lesion as SIGNIFICANT (FFR < 0.75), NOT SIGNIFICANT (FFR > or = 0.75), or UNSURE if the observer was unable to make a decision based on the angiogram. RESULTS: Mean follow-up was 29 +/- 13.6 months. No death or myocardial infarction was observed, event-free survival was 69 %. When taking the "unsure" classifications into consideration the individual reviewers achieved correct lesion classification with respect to FFR results on average in 58 % to 82 % of cases. Interobserver variability resulted in only 46 % of cases in concordant lesion classification (3 agreements or 2 agreements and 1 "unsure" evaluation). The number of concordant agreements between the individual pairs of reviewers did not exceed the rate of coincidental agreements that could be expected to result from simple guessing (mean KAPPA coefficient 0.04). More than 50 % of patients with excellent long-term outcome after deferral of surgery would potentially have undergone operative revascularization if consensual decision making had been solely based on angiographic lesion assessment. CONCLUSION: The functional significance of intermediate or equivocal LMCA lesions should not be based on visual assessment alone, even when performed by experienced interventional cardiologists.


Assuntos
Determinação da Pressão Arterial/normas , Pressão Sanguínea/fisiologia , Angiografia Coronária/normas , Circulação Coronária/fisiologia , Estenose Coronária/diagnóstico , Vasos Coronários/fisiologia , Determinação da Pressão Arterial/métodos , Estenose Coronária/diagnóstico por imagem , Estenose Coronária/fisiopatologia , Vasos Coronários/fisiopatologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Variações Dependentes do Observador , Reprodutibilidade dos Testes , Estudos Retrospectivos , Método Simples-Cego
8.
Int J Cardiol ; 99(1): 19-23, 2005 Mar 10.
Artigo em Inglês | MEDLINE | ID: mdl-15721494

RESUMO

BACKGROUND: Coronary angiographies performed during acute coronary syndrome show different coronary morphologies-vessel occlusions, thrombi and various types of stenoses. In a few cases of acute coronary syndrome, angiography reveals normal coronary arteries. It is the purpose of this study to analyze this specific subset of patients who presented with an acute coronary syndrome but had a normal coronary angiogram with respect to the preangiographic diagnostics, risk stratification and clinical follow-up. METHODS AND RESULTS: A total of 897 coronary angiographies were performed as an emergency procedure in our institution. The majority of patients (n = 821) presented with coronary artery disease and the majority was treated by mechanical revascularization (86.3%). In 76 patients (8.5%), no coronary artery stenosis was documented. However, according to the preangiographic risk stratification, coronary artery disease was expected in these patients. Observations documented angiographically included coronary spasms (6.6%) and muscle bridges (5.3%). During a mean follow-up of 11.2 +/- 6.4 months, one patient developed an acute myocardial infarction requiring coronary intervention. All other patients were free of any cardiac event. CONCLUSIONS: In summary, we have to consider that coronary angiography may not always detect the cause of myocardial ischemia in every patient. There is a small group of patients with normal coronary angiograms during acute coronary syndrome. Additional diagnostic procedures like intravascular ultrasound (IVUS) or the assessment of intracoronary physiological parameters may increase the diagnostic value of angiography.


Assuntos
Angina Instável/diagnóstico por imagem , Angiografia Coronária , Infarto do Miocárdio/diagnóstico por imagem , Doença Aguda , Angina Instável/terapia , Seguimentos , Humanos , Infarto do Miocárdio/terapia , Valores de Referência , Medição de Risco , Síndrome
9.
Z Kardiol ; 94(1): 23-7, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15668826

RESUMO

Aggressive antithrombotic medical therapy may increase the rate of access-site complications after percutaneous coronary intervention. Frequently, emergency coronary interventions have to be performed in a situation when thrombolysis therapy was administered as the first-line therapeutic approach in acute myocardial infarction but failed to achieve stable conditions. We analyzed the rate of femoral bleeding complications after emergency coronary intervention in 76 consecutive patients with unsuccessful thrombolysis in acute myocardial infarction. All invasive procedures were performed in a time period no longer than eight hours after thrombolysis was administered. Additional antithrombotic therapy with heparin and glycoprotein IIb/IIIa-inhibitors was given during intervention in 100% and 38.2% of patients, respectively. In three patients (3.9%) femoral hematomas without therapeutic consequences were documented; one patient (1.3%) developed a hematoma requiring blood transfusion. A pseudoaneurysm, fistula or surgical vascular intervention did not occur. Coronary interventional procedures in rescue situations can be performed with excellent safety with respect to access-site bleeding complications even under conditions of ongoing thrombolysis therapy and aggressive antithrombotic medical regimens.


Assuntos
Angioplastia Coronária com Balão , Angiografia Coronária , Emergências , Artéria Femoral , Fibrinolíticos/efeitos adversos , Infarto do Miocárdio/terapia , Hemorragia Pós-Operatória/induzido quimicamente , Terapia Trombolítica , Idoso , Idoso de 80 Anos ou mais , Quimioterapia Combinada , Feminino , Fibrinolíticos/uso terapêutico , Hematoma/induzido quimicamente , Heparina/efeitos adversos , Heparina/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/diagnóstico por imagem , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/efeitos adversos , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/uso terapêutico , Retratamento , Fatores de Risco , Falha de Tratamento
10.
Biomed Tech (Berl) ; 48(5): 135-40, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12838796

RESUMO

Intravascular Ultrasound (IVUS) is routinely used in interventional cardiology for imaging coronary plaque morphology. However, the use of B-mode images for tissue characterization and detection of vulnerable coronary plaques is limited. Strain imaging with ultrasound is a new modality that provides additional information for tissue characterization by imaging differences in tissue stiffness. The aim is to differentiate between vulnerable (soft) plaques and less dangerous calcified (hard) plaques. In this work, the applicability of a time efficient strain imaging algorithm in conjunction with data from IVUS array transducers is evaluated. Unfocused radiofrequency (rf) data from the transducer array is acquired using custom made hardware. Rf line reconstruction is performed offline by synthetic aperture focusing techniques. Vessel mimicking phantoms of different geometries and material stiffness are made from agar and Polyvinyl Alcohol Cryogel (PVA). Experiments are conducted in a water tank and a water column is used for applying intraluminal pressure differences required for strain imaging. The results show that strain images can be calculated with A-lines reconstructed from unfocused rf raw data. Regions of different stiffness can be identified qualitatively by local strain variations. With the used algorithm strains of up to 2% can be imaged without significant decor-relation.


Assuntos
Doença da Artéria Coronariana/diagnóstico por imagem , Processamento de Imagem Assistida por Computador/instrumentação , Imagens de Fantasmas , Ultrassonografia de Intervenção/instrumentação , Algoritmos , Calcinose/diagnóstico por imagem , Computadores , Vasos Coronários/diagnóstico por imagem , Elasticidade , Humanos , Modelos Cardiovasculares , Resistência ao Cisalhamento , Transdutores
11.
J Invasive Cardiol ; 13(6): 431-6, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11385163

RESUMO

A combined antiplatelet treatment with ticlopidine and aspirin has been accepted as standard pharmacological regimen after coronary artery stenting. No data of a randomized trial are available on ticlopidine monotherapy. This prospective, randomized monocenter trial investigates the role of ticlopidine monotherapy versus combined antiplatelet therapy with ticlopidine and aspirin in unselected patients undergoing coronary artery stenting. After successful placement of 378 coronary artery stents, two hundred and forty-three consecutive patients were randomly assigned to receive antiplatelet therapy with 2 x 250 mg ticlopidine (121 patients) or a combination of 2 x 250 mg ticlopidine plus 100 mg aspirin (122 patients) daily. The primary endpoint included the absence of death, cardiac events and vascular access-site complications during the in-hospital phase. Angiographic and clinical assessment was repeated at the 3-month follow-up exam. Two hundred and thirty-seven patients (97.5%) were free from cardiac and non-cardiac events. Stent thromboses were seen in 2 patients of the combined treatment group, while none were observed in the monotherapy group. No statistically significant differences were found between the 2 groups regarding the primary endpoint. Angiography performed in 210 patients (86.4%) at follow-up revealed a restenosis rate of 29.4% in the combined treatment group and 27.8% in the monotherapy group. Monotherapy with ticlopidine is as safe and effective as a combined regimen of ticlopidine plus aspirin after coronary artery stenting in an unselected patient population. These results need to be confirmed in a larger multicenter trial.


Assuntos
Doença das Coronárias/tratamento farmacológico , Doença das Coronárias/cirurgia , Inibidores da Agregação Plaquetária/uso terapêutico , Stents , Idoso , Aspirina/uso terapêutico , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Ticlopidina/uso terapêutico , Resultado do Tratamento
12.
Clin Rheumatol ; 20(6): 441-3, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11771532

RESUMO

Although infectious agents such as Staphylococcus aureus have been implicated in the pathogenesis of Wegener's granulomatosis, the role of bacterial infections in the pathogenesis of other types of small-vessel vasculitides associated with antineutrophil cytoplasmic antibodies (ANCA) is less clear. We describe a patient who developed a non-granulomatous necrotising small vessel vasculitis and perinuclear ANCA (p-ANCA) directed against myeloperoxidase (MPO) after recurrent episodes of bacterial endocarditis due to Staph. aureus. Although cytoplasmic ANCA (c-ANCA) directed against proteinase 3 have been reported in single patients with bacterial endocarditis, to our knowledge this patient is the first reported case of an anti-MPO-ANCA positive systemic vasculitis following bacterial endocarditis.


Assuntos
Anticorpos Anticitoplasma de Neutrófilos/análise , Endocardite Bacteriana Subaguda/complicações , Peroxidase/imunologia , Infecções Estafilocócicas/complicações , Vasculite/etiologia , Humanos , Masculino , Microcirculação , Pessoa de Meia-Idade , Recidiva , Vasculite/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...